Evidence-Based Medicine Guidelines
Anti‐vascular endothelial growth factor for proliferative diabetic retinopathy
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Anti‐vascular Endothelial Growth Factor for Proliferative Diabetic Retinopathy." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/1305540/all/Anti‐vascular_endothelial_growth_factor_for_proliferative_diabetic_retinopathy.
Anti‐vascular endothelial growth factor for proliferative diabetic retinopathy. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305540/all/Anti‐vascular_endothelial_growth_factor_for_proliferative_diabetic_retinopathy. Accessed May 19, 2025.
Anti‐vascular endothelial growth factor for proliferative diabetic retinopathy. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305540/all/Anti‐vascular_endothelial_growth_factor_for_proliferative_diabetic_retinopathy
Anti‐vascular Endothelial Growth Factor for Proliferative Diabetic Retinopathy [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 May 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/1305540/all/Anti‐vascular_endothelial_growth_factor_for_proliferative_diabetic_retinopathy.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Anti‐vascular endothelial growth factor for proliferative diabetic retinopathy
ID - 1305540
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/1305540/all/Anti‐vascular_endothelial_growth_factor_for_proliferative_diabetic_retinopathy
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
